Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $24.6300 (2.93%) ($23.3900 - $24.6800) on Tue. Aug. 6, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.33% (three month average) | RSI | 55 | Latest Price | $24.6300(2.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.7% a day on average for past five trading days. | Weekly Trend | EDIT advances 0.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(60%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -1.665% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-6%) IFRA(-5%) TLT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.665% (StdDev 3.33%) | Hourly BBV | 0 () | Intraday Trend | 2.8% | | | |
|
Resistance Level | $25.1 | 5 Day Moving Average | $24.91(-1.12%) | 10 Day Moving Average | $25.44(-3.18%) | 20 Day Moving Average | $25.1(-1.87%) | To recent high | -8.1% | To recent low | 20.3% | Market Cap | $1.53b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |